Jimmy Roselli - Let Me Sing and I’ll Be Happy (CD)

Jimmy Roselli - Let Me Sing and I’ll Be Happy (CD)

Marsoni

M251S

$12.80

Get it in 3 business days with 1 day shipping. Friday, May 29

Jimmy Roselli - Let Me Sing and I’ll Be Happy (CD)The words and melodies here are symbols of another time, another era. Listen, as Jimmy takes you on a tour of yesteryear, when a man named George Herman Ruth was the home run king, when Valentino ruled the silver screen, when Jolson, Gershwin, and Khan ruled the stage. Track Listing Let Me Sing and Im Happy Sonny Boy All By Myself Swanee Toot Toot Tootsie (Goodbye) Back in Your own Back Yard April Showers Anniversary Song Liza (All the Cloudsll Roll

Easy Shipping

Quick Dispatch:

Your Jimmy Roselli - Let Me Sing and I’ll Be Happy (CD) orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Jimmy Roselli - Let Me Sing and I’ll Be Happy (CD) ships.

Need Help?
Questions about Jimmy Roselli - Let Me Sing and I’ll Be Happy (CD), sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Jimmy Roselli - Let Me Sing and I’ll Be Happy (CD) in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Uriel Kosayev did it again! MAoS is his second book, following his great first one, Antivirus Bypass Techniques. This new book takes things to the next level with a deep dive into real-world malware and reverse engineering tactics that every security researcher can learn from. It’s packed with practical examples and insights that clearly come from real experience in the field. If you’re into malware analysis or cybersecurity research, this book is a must-read. Uriel’s passion and expertise truly stand out on every page. Highly recommended!

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on October 25, 2025

eyal Fishman

Boise, US

★★★★★ 5

outstanding and highly informative book

Format: Paperback

MAoS - Malware Analysis on Steroids: Fighting Malware to the Death - Real-World Threats and Reverse Engineering Tactics by Uriel Kosayev is an outstanding and highly informative book. This is the second book I’ve read from him, after Antivirus Bypass Techniques, and once again I found the content to be extremely practical, well-structured, and insightful. Uriel has a way of explaining complex malware analysis and reverse engineering concepts in a way that is both approachable and deeply technical. The real-world tactics and examples make it not just a book you read once, but a reference you’ll return to often. Without a doubt, another excellent resource—I’m giving it 5 stars.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on September 10, 2025

Verified Purchase

Arthur Donkers

Birmingham, US

★★★★★ 4

good

Format: Paperback

Good practical content, quality of images could be improved

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on October 13, 2025

Zachi

Carnegie, US

★★★★★ 5

Essential for Malware Hunters

Format: Hardcover

MAoS - Malware Analysis on Steroids is a clear, practical, and engaging guide to real-world malware threats. It blends hands-on reverse engineering tactics with modern case studies, making it both highly technical and easy to follow. Whether you’re new to malware analysis or a seasoned security pro, this book sharpens your skills and mindset for the fight against today’s threats.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on September 20, 2025

Verified Purchase

Cliente Amazon

Cuba, US

★★★★★ 5

All OK.

Format: Paperback

All OK.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on August 23, 2024